These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 2855293

  • 21. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP, Karlberg BE, Nilsson OR, Wettre S.
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [Abstract] [Full Text] [Related]

  • 22. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 23. A comparative study of endralazine and captopril in essential hypertension: effect on renin levels, pulmonary function studies and lipid profile.
    Hauger-Klevene JH, Reader C, Mayer E, Sanchez MR.
    Int J Clin Pharmacol Res; 1986 Oct; 6(4):275-81. PubMed ID: 3531038
    [Abstract] [Full Text] [Related]

  • 24. [Mechanisms of the hypotensive action of captopril in essential hypertension].
    Ustinova SE, Zhukova IM, Uchitel' IA, Parfenova EV, Chernova NA.
    Kardiologiia; 1986 Dec; 26(12):72-6. PubMed ID: 3031355
    [Abstract] [Full Text] [Related]

  • 25. Effects of a single administration of captopril on hemodynamics and serum angiotensin converting enzyme activity, plasma renin activity and plasma aldosterone concentration in hypertensive patients.
    Hashimoto H, Hiwada K, Kokubu T.
    Jpn Circ J; 1981 Feb; 45(2):176-80. PubMed ID: 6262543
    [Abstract] [Full Text] [Related]

  • 26. [Plasma leucine enkephalin and beta-endorphin levels in patients with essential hypertension and the effects of captopril].
    Gao Y.
    Zhonghua Yi Xue Za Zhi; 1990 Jun; 70(6):327-9, 24. PubMed ID: 2169983
    [Abstract] [Full Text] [Related]

  • 27. [The efficacy of the captopril treatment of elderly hypertension patients].
    Korkushko OV, Fedirko MI, Gidzinskaia IN.
    Vrach Delo; 1990 Feb; (2):10-3. PubMed ID: 2187303
    [Abstract] [Full Text] [Related]

  • 28. Humoral and hemodynamic effects of increasing doses of captopril in patients with essential hypertension.
    Sassano P, Pedrinelli R, Magagna A, Abdel-Haq B, Salvetti A.
    Am J Cardiol; 1982 Apr 21; 49(6):1574-6. PubMed ID: 6280486
    [Abstract] [Full Text] [Related]

  • 29. [Effect of long-term treatment with guanfacine on selected humoral metabolic indices in patients with primary hypertension].
    Knypl K, Wocial B, Chodakowska J, Brym E, Czerniewska E, Wacławek-Maczkowska J, Kuczyńska K, Berent H, Januszewicz W.
    Pol Tyg Lek; 1982 Apr 21; 44(12-13):293-6. PubMed ID: 2530502
    [Abstract] [Full Text] [Related]

  • 30. Comparison of once-daily captopril or enalapril in mild essential hypertension.
    Pixley JS, Marshall MK, Stanley H, Starich GH, Ferguson RK.
    J Clin Pharmacol; 1989 Feb 21; 29(2):118-22. PubMed ID: 2541177
    [Abstract] [Full Text] [Related]

  • 31. Dilation of forearm blood vessels after angiotensin-converting-enzyme inhibition by captopril in hypertensive patients.
    Johns DW, Ayers CR, Williams SC.
    Hypertension; 1984 Feb 21; 6(4):545-50. PubMed ID: 6086518
    [Abstract] [Full Text] [Related]

  • 32. Renin-angiotensin system and opioids during acute hemorrhage in conscious rabbits.
    Schadt JC, Gaddis RR.
    Am J Physiol; 1990 Feb 21; 258(2 Pt 2):R543-51. PubMed ID: 2155547
    [Abstract] [Full Text] [Related]

  • 33. Comparison of sublingual and oral captopril in hypertension.
    Dessì-Fulgheri P, Bandiera F, Rubattu S, Cocco F, Madeddu P, Oppes M, Tonolo GC, Glorioso N, Rappelli A.
    Clin Exp Hypertens A; 1987 Feb 21; 9(2-3):593-7. PubMed ID: 3038422
    [Abstract] [Full Text] [Related]

  • 34. Influence of food on acute and chronic effects of captopril in essential hypertensive patients.
    Salvetti A, Pedrinelli R, Magagna A, Abdel-Haq B, Graziadei L, Taddei S, Stornello M.
    J Cardiovasc Pharmacol; 1985 Feb 21; 7 Suppl 1():S25-9. PubMed ID: 2580172
    [Abstract] [Full Text] [Related]

  • 35. [Gonadectomy-induced reduction of antihypertensive action of angiotensin converting enzyme inhibitor and its role of central renin activity in spontaneously hypertensive rats].
    Kumai T.
    Nihon Naibunpi Gakkai Zasshi; 1991 Nov 20; 67(11):1231-9. PubMed ID: 1662161
    [Abstract] [Full Text] [Related]

  • 36. Angiotensin I converting enzyme activity in hypertension. Relationship to blood pressure, renin-sodium profiles, and antihypertensive therapy.
    Niarchos AP, Resnick LM, Weinstein DL, Laragh JH.
    Am J Med; 1985 Oct 20; 79(4):435-44. PubMed ID: 2864856
    [Abstract] [Full Text] [Related]

  • 37. [Effect of a single dose of intravenous captopril in hypertensive subjects].
    Franchi M, Puccetti F, Landini F, Burresi A, Di Perri T.
    Recenti Prog Med; 1988 Jun 20; 79(6):261-6. PubMed ID: 2843976
    [No Abstract] [Full Text] [Related]

  • 38. The influence of naloxone on the circulatory effects of captopril.
    Rubin PC, Millar JA, Sturani S, Lawrie C, Reid JL.
    Br J Clin Pharmacol; 1984 Jun 20; 17(6):713-7. PubMed ID: 6331480
    [Abstract] [Full Text] [Related]

  • 39. [Use of captopril (capoten) in arterial hypertension].
    Erina EV, Zhukova IM, Ustinova SE, D'iakonova EG, Masenko VP.
    Kardiologiia; 1985 Jun 20; 25(6):19-24. PubMed ID: 3900522
    [Abstract] [Full Text] [Related]

  • 40. Naloxone does not antagonize the antihypertensive effect of chronic captopril therapy in hypertensive patients.
    Bernini GP, Lucarini AR, Vivaldi MS, Del Corso C, Lenzi M, Salvetti A.
    Cardiovasc Drugs Ther; 1989 Dec 20; 3(6):829-33. PubMed ID: 2487544
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.